Refine
Year of publication
Has Fulltext
- yes (24)
Is part of the Bibliography
- no (24)
Keywords
- Non-small cell lung cancer (2)
- B cell receptor (1)
- Baryonic resonances (1)
- Biomarkers (1)
- Büchner (1)
- Chemotherapy (1)
- Cherenkov counter: lead-glass (1)
- Cognitive impairment (1)
- Cohort studies (1)
- Drug screens (1)
- Eichendorff (1)
- Electron-pion identification (1)
- FAPI PET (1)
- Fibre/foam sandwich radiator (1)
- Freezeout (1)
- Georg (1)
- HADES (1)
- Heavy-ion reactions (1)
- Hematology (1)
- Ionisation energy loss (1)
- Joseph von (1)
- Leukemias (1)
- Liebe (1)
- Ludwig (1)
- Lung Cancer (1)
- Molecular diagnostic testing (1)
- Multi-wire proportional drift chamber (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- Neural network (1)
- Oncology (1)
- Parkinson disease (1)
- Prognosis (1)
- ROS1 (1)
- Registries (1)
- TR (1)
- Tieck (1)
- Tracking (1)
- Transition radiation detector (1)
- Trigger (1)
- Xenon-based gas mixture (1)
- calorimeter: electromagnetic (1)
- dE/dx (1)
- electronics: readout (1)
- fibre: optical (1)
- fibrosis imaging (1)
- nuclear cardiology (1)
- stability (1)
Institute
- Physik (13)
- Medizin (7)
- Frankfurt Institute for Advanced Studies (FIAS) (6)
- Informatik (6)
- Neuere Philologien (2)
Transverse momentum (pT) spectra of pions, kaons, and protons up to pT=20 GeV/c have been measured in Pb-Pb collisions at sNN−−−√=2.76 TeV using the ALICE detector for six different centrality classes covering 0-80%. The proton-to-pion and the kaon-to-pion ratios both show a distinct peak at pT≈3 GeV/c in central Pb-Pb collisions that decreases towards more peripheral collisions. For pT>10 GeV/c, the nuclear modification factor is found to be the same for all three particle species in each centrality interval within systematic uncertainties of 10-20%. This suggests there is no direct interplay between the energy loss in the medium and the particle species composition in the hard core of the quenched jet. For pT<10 GeV/c, the data provide important constraints for models aimed at describing the transition from soft to hard physics.
We present data on charged kaons (K±) and ϕ mesons in Au(1.23A GeV)+Au collisions. It is the first simultaneous measurement of K− and ϕ mesons in central heavy-ion collisions below a kinetic beam energy of 10A GeV. The ϕ/K− multiplicity ratio is found to be surprisingly high with a value of 0.52±0.16 and shows no dependence on the centrality of the collision. Consequently, the different slopes of the K+ and K− transverse-mass spectra can be explained solely by feed-down, which substantially softens the spectra of K− mesons. Hence, in contrast to the commonly adapted argumentation in literature, the different slopes do not necessarily imply diverging freeze-out temperatures of K+ and K− mesons caused by different couplings to baryons.
No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
(2019)
Background: IgG-class autoantibodies to N-Methyl-D-Aspartate (NMDA)-type glutamate receptors define a novel entity of autoimmune encephalitis. Studies examining the prevalence of NMDA IgA/IgM antibodies in patients with Parkinson disease with/without dementia produced conflicting results. We measured NMDA antibodies in a large, well phenotyped sample of Parkinson patients without and with cognitive impairment (n = 296) and controls (n = 295) free of neuropsychiatric disease. Detailed phenotyping and large numbers allowed statistically meaningful correlation of antibody status with diagnostic subgroups as well as quantitative indicators of disease severity and cognitive impairment.
Methods: NMDA antibodies were analysed in the serum of patients and controls using well established validated assays. We used anti-NMDA antibody positivity as the main independent variable and correlated it with disease status and phenotypic characteristics.
Results: The frequency of NMDA IgA/IgM antibodies was lower in Parkinson patients (13%) than in controls (22%) and higher than in previous studies in both groups. NMDA IgA/IgM antibodies were neither significantly associated with diagnostic subclasses of Parkinson disease according to cognitive impairment, nor with quantitative indicators of disease severity and cognitive impairment. A positive NMDA antibody status was positively correlated with age in controls but not in Parkinson patients.
Conclusion: It is unlikely albeit not impossible that NMDA antibodies play a significant role in the pathogenesis or progression of Parkinson disease e.g. to Parkinson disease with dementia, while NMDA IgG antibodies define a separate disease of its own.